These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 329521

  • 1. Malignancies associated with renal transplantation.
    Penn I.
    Urology; 1977 Jul; 10(1 Suppl):57-63. PubMed ID: 329521
    [Abstract] [Full Text] [Related]

  • 2. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V.
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [Abstract] [Full Text] [Related]

  • 3. Malignant tumours following immunosuppression in renal transplantation.
    Birkeland SA, Kemp E.
    Proc Eur Dial Transplant Assoc; 1973 Jun; 10(0):429-33. PubMed ID: 4370181
    [No Abstract] [Full Text] [Related]

  • 4. Tumor incidence in human allograft recipients.
    Penn I.
    Transplant Proc; 1979 Mar; 11(1):1047-51. PubMed ID: 377608
    [No Abstract] [Full Text] [Related]

  • 5. De novo malignant tumors in organ transplant recipients.
    Penn I, Halgrimson CG, Starzl TE.
    Transplant Proc; 1971 Mar; 3(1):773-8. PubMed ID: 4937971
    [No Abstract] [Full Text] [Related]

  • 6. [Tumors and kidney transplantation].
    Brünisholz M, Hodel K, Brunner FP, Harder F, Torhorst J, Thiel G.
    Schweiz Med Wochenschr; 1984 Dec 22; 114(51):1915-24. PubMed ID: 6395328
    [Abstract] [Full Text] [Related]

  • 7. Neoplastic complications of transplantation.
    Penn I.
    Semin Respir Infect; 1993 Sep 22; 8(3):233-9. PubMed ID: 8016484
    [Abstract] [Full Text] [Related]

  • 8. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J.
    Liver Transpl; 2002 May 22; 8(5):482-7. PubMed ID: 12004349
    [Abstract] [Full Text] [Related]

  • 9. Incidence and treatment of neoplasia after transplantation.
    Penn I.
    J Heart Lung Transplant; 1993 May 22; 12(6 Pt 2):S328-36. PubMed ID: 8312352
    [Abstract] [Full Text] [Related]

  • 10. Malignant tumors arising de novo in immunosuppressed organ transplant recipients.
    Penn I, Starzl TE.
    Transplantation; 1972 Oct 22; 14(4):407-17. PubMed ID: 4345337
    [Abstract] [Full Text] [Related]

  • 11. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM.
    Arch Dermatol; 1995 Apr 22; 131(4):432-5. PubMed ID: 7726585
    [Abstract] [Full Text] [Related]

  • 12. Early de novo malignancies after kidney transplantation.
    Veroux M, Puliatti C, Fiamingo P, Cappello D, Macarone M, Puliatti D, Vizcarra D, Gagliano M, Veroux P.
    Transplant Proc; 2004 Apr 22; 36(3):718-20. PubMed ID: 15110643
    [Abstract] [Full Text] [Related]

  • 13. Cancer and survival after cadaveric donor renal transplantation.
    Sheil AG, Mahoney JF, Horvath JS, Johnson JR, Tiller DJ, May J, Stewart JH.
    Transplant Proc; 1979 Mar 22; 11(1):1052-4. PubMed ID: 377609
    [No Abstract] [Full Text] [Related]

  • 14. De novo malignances in pediatric organ transplant recipients.
    Penn I.
    Pediatr Transplant; 1998 Feb 22; 2(1):56-63. PubMed ID: 10084762
    [Abstract] [Full Text] [Related]

  • 15. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M, Watorek E, Smolska D, Patrzałek D, Klinger M.
    Transplant Proc; 2007 Nov 22; 39(9):2736-9. PubMed ID: 18021973
    [Abstract] [Full Text] [Related]

  • 16. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y, Lay F, Luccioni A, Daniel L, Berland Y, Coulange C, Lechevallier E.
    Cancer; 2005 Jan 15; 103(2):251-7. PubMed ID: 15593084
    [Abstract] [Full Text] [Related]

  • 17. Cancer is a complication of severe immunosuppression.
    Penn I.
    Surg Gynecol Obstet; 1986 Jun 15; 162(6):603-10. PubMed ID: 3520906
    [Abstract] [Full Text] [Related]

  • 18. Risk factors associated with the development of skin cancer after liver transplantation.
    Mithoefer AB, Supran S, Freeman RB.
    Liver Transpl; 2002 Oct 15; 8(10):939-44. PubMed ID: 12360438
    [Abstract] [Full Text] [Related]

  • 19. Incidence and types of malignancies in renal transplant recipients in Iraq.
    Altaee IK, Jaleel NA, Aljubury HM, Alshamaa IA, Gazala S.
    Saudi J Kidney Dis Transpl; 2006 Sep 15; 17(3):408-14. PubMed ID: 16970265
    [Abstract] [Full Text] [Related]

  • 20. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases.
    Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A.
    Arch Dermatol; 2003 Sep 15; 139(9):1133-7. PubMed ID: 12975154
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.